OBJECTIVE: Virus infections are the most common causes of encephalitis, a syndrome characterized by acute inflammation of the brain. More than 150 different viruses have been implicated in the pathogenesis of encephalitis; however, because of limitations with diagnostic testing, causative factors of more than half of the cases remain unknown. METHODS: To investigate whether human herpesvirus-6 (HHV-6) is a causative agent of encephalitis, we examined for evidence of virus infection by determining the presence of viral sequence using polymerase chain reaction and assessed HHV-6 antibody reactivity in the cerebrospinal fluid of encephalitis patients with unknown cause. In a cohort study, we compared virus-specific antibody levels in cerebrospinal fluid samples of patients with encephalitis, relapsing-remitting multiple sclerosis, and other neurological diseases. RESULTS: Our results demonstrated increased levels of HHV-6 IgG, as well as IgM levels, in a subset of encephalitis patients compared with other neurological diseases. Moreover, cell-free viral DNA that is indicative of active infection was detected in 40% (14/35) of encephalitis patients, whereas no amplifiable viral sequence was found in either relapsing-remitting MS or other neurological diseases patients. In addition, a significant correlation between polymerase chain reaction detection and anti-HHV-6 antibody response was also demonstrated. INTERPRETATION: Collectively, these results suggested HHV-6 as a possible pathogen in a subset of encephalitis cases.
OBJECTIVE:Virus infections are the most common causes of encephalitis, a syndrome characterized by acute inflammation of the brain. More than 150 different viruses have been implicated in the pathogenesis of encephalitis; however, because of limitations with diagnostic testing, causative factors of more than half of the cases remain unknown. METHODS: To investigate whether human herpesvirus-6 (HHV-6) is a causative agent of encephalitis, we examined for evidence of virus infection by determining the presence of viral sequence using polymerase chain reaction and assessed HHV-6 antibody reactivity in the cerebrospinal fluid of encephalitispatients with unknown cause. In a cohort study, we compared virus-specific antibody levels in cerebrospinal fluid samples of patients with encephalitis, relapsing-remitting multiple sclerosis, and other neurological diseases. RESULTS: Our results demonstrated increased levels of HHV-6 IgG, as well as IgM levels, in a subset of encephalitispatients compared with other neurological diseases. Moreover, cell-free viral DNA that is indicative of active infection was detected in 40% (14/35) of encephalitispatients, whereas no amplifiable viral sequence was found in either relapsing-remitting MS or other neurological diseasespatients. In addition, a significant correlation between polymerase chain reaction detection and anti-HHV-6 antibody response was also demonstrated. INTERPRETATION: Collectively, these results suggested HHV-6 as a possible pathogen in a subset of encephalitis cases.
Authors: M Mayne; C Cheadle; S S Soldan; C Cermelli; Y Yamano; N Akhyani; J E Nagel; D D Taub; K G Becker; S Jacobson Journal: J Virol Date: 2001-12 Impact factor: 5.103
Authors: Erin Isaacson; Carol A Glaser; Bagher Forghani; Zahwa Amad; Mark Wallace; Robert W Armstrong; Maurice M Exner; Scott Schmid Journal: Clin Infect Dis Date: 2005-02-21 Impact factor: 9.079
Authors: Roberto Alvarez-Lafuente; Virginia De Las Heras; Manuel Bartolomé; Marta García-Montojo; Rafael Arroyo Journal: Brain Pathol Date: 2006-01 Impact factor: 6.508
Authors: Mary Alice Allnutt; Kory Johnson; David A Bennett; Sarah M Connor; Juan C Troncoso; Olga Pletnikova; Marilyn S Albert; Susan M Resnick; Sonja W Scholz; Philip L De Jager; Steven Jacobson Journal: Neuron Date: 2020-01-23 Impact factor: 17.173
Authors: E Bozzola; A Krzysztofiak; M Bozzola; V Calcaterra; A Quondamcarlo; L Lancella; A Villani Journal: Infection Date: 2012-07-18 Impact factor: 3.553
Authors: Peter D Burbelo; Ahmad Bayat; Jason Wagner; Thomas B Nutman; James N Baraniuk; Michael J Iadarola Journal: Am J Transl Res Date: 2012-10-10 Impact factor: 4.060
Authors: Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius Journal: Drugs Date: 2013-02 Impact factor: 9.546